Interestingly, various studies have shown that DPP-4 inhibitors exhibit different effects depending on glucose levels: in hyperglycemia, DPP-4 inhibitors inhibit glucagon secretion, while in hypoglycemia, they enhance glucagon secretion [116,117]. Here, DPP4 is linked to Hypoglycemia.